646 related articles for article (PubMed ID: 36618350)
1. Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics.
Pal S; Sharma A; Mathew SP; Jaganathan BG
Front Immunol; 2022; 13():955476. PubMed ID: 36618350
[TBL] [Abstract][Full Text] [Related]
2. Metabolic Pathways Regulating Colorectal Cancer: A Potential Therapeutic Approach.
Zafari N; Velayati M; Damavandi S; Pourali G; Mobarhan MG; Nassiri M; Hassanian SM; Khazaei M; Ferns GA; Avan A
Curr Pharm Des; 2022; 28(36):2995-3009. PubMed ID: 36154599
[TBL] [Abstract][Full Text] [Related]
3. Targeting metabolic reprogramming in KRAS-driven cancers.
Kawada K; Toda K; Sakai Y
Int J Clin Oncol; 2017 Aug; 22(4):651-659. PubMed ID: 28647837
[TBL] [Abstract][Full Text] [Related]
4. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
[TBL] [Abstract][Full Text] [Related]
5. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.
Li C; Zhang G; Zhao L; Ma Z; Chen H
World J Surg Oncol; 2016 Jan; 14(1):15. PubMed ID: 26791262
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma.
Pang Y; Lu T; Xu-Monette ZY; Young KH
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982568
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay.
Fiaschi T; Marini A; Giannoni E; Taddei ML; Gandellini P; De Donatis A; Lanciotti M; Serni S; Cirri P; Chiarugi P
Cancer Res; 2012 Oct; 72(19):5130-40. PubMed ID: 22850421
[TBL] [Abstract][Full Text] [Related]
8. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
[TBL] [Abstract][Full Text] [Related]
9. The Emerging Hallmarks of Cancer Metabolism.
Pavlova NN; Thompson CB
Cell Metab; 2016 Jan; 23(1):27-47. PubMed ID: 26771115
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Rewiring in Cancer: Small Molecule Inhibitors in Colorectal Cancer Therapy.
Masci D; Puxeddu M; Silvestri R; La Regina G
Molecules; 2024 May; 29(9):. PubMed ID: 38731601
[TBL] [Abstract][Full Text] [Related]
11. Research progress of hyperthermia in tumor therapy by influencing metabolic reprogramming of tumor cells.
Yang Y; Huangfu L; Li H; Yang D
Int J Hyperthermia; 2023; 40(1):2270654. PubMed ID: 37871910
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial and metabolic alterations in cancer cells.
Di Gregorio J; Petricca S; Iorio R; Toniato E; Flati V
Eur J Cell Biol; 2022; 101(3):151225. PubMed ID: 35453093
[TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
Martinez-Outschoorn U; Sotgia F; Lisanti MP
Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
[TBL] [Abstract][Full Text] [Related]
14. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
Yoshida GJ
J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
[TBL] [Abstract][Full Text] [Related]
15. Oncogene-Driven Metabolic Alterations in Cancer.
Min HY; Lee HY
Biomol Ther (Seoul); 2018 Jan; 26(1):45-56. PubMed ID: 29212306
[TBL] [Abstract][Full Text] [Related]
16. Perspectives of Reprogramming Breast Cancer Metabolism.
Wang YP; Lei QY
Adv Exp Med Biol; 2017; 1026():217-232. PubMed ID: 29282686
[TBL] [Abstract][Full Text] [Related]
17. LKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseases.
Zhang Y; Meng Q; Sun Q; Xu ZX; Zhou H; Wang Y
Mol Metab; 2021 Feb; 44():101131. PubMed ID: 33278637
[TBL] [Abstract][Full Text] [Related]
18. Metabolic and Amino Acid Alterations of the Tumor Microenvironment.
Stepka P; Vsiansky V; Raudenska M; Gumulec J; Adam V; Masarik M
Curr Med Chem; 2021; 28(7):1270-1289. PubMed ID: 32031065
[TBL] [Abstract][Full Text] [Related]
19. Revisited Metabolic Control and Reprogramming Cancers by Means of the Warburg Effect in Tumor Cells.
Fukushi A; Kim HD; Chang YC; Kim CH
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077431
[TBL] [Abstract][Full Text] [Related]
20. Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis.
Liu T; Kishton RJ; Macintyre AN; Gerriets VA; Xiang H; Liu X; Abel ED; Rizzieri D; Locasale JW; Rathmell JC
Cell Death Dis; 2014 Oct; 5(10):e1470. PubMed ID: 25321477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
